£790.00

The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis

Price data last checked 148 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£790 today · cheaper than every other day in the last 15 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 301 days • 301 data points (No recent data available)

Historical
Generating forecast...
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 20 March 2025 03 June 2025 17 August 2025 31 October 2025 14 January 2026

Price Distribution

Price distribution over 301 days • 1 price levels

Days at Price
301 days 0 75 151 226 301 £790 Days at Price

Price Analysis

Most common price: £790 (301 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 301 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
07 May 2024

Similar Products You Might Like

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
99% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

£515.00 11 Jan 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States
99% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States

£520.00 09 Jan 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan
99% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan

£495.00 05 Jan 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes
98% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes

£490.00 13 Feb 2026
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
97% match

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

£595.00 14 Jan 2026
The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City
97% match

The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

£995.00 23 Jan 2026
The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City
97% match

The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City

£795.00 06 Apr 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 World Outlook for Advanced Therapy Medicinal Products
96% match

The 2023-2028 World Outlook for Advanced Therapy Medicinal Products

£795.00 12 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
96% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States

£520.00 29 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India
96% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India

£515.00 06 Feb 2026
The 2026-2031 World Outlook for Digital Therapeutics Sales
96% match

The 2026-2031 World Outlook for Digital Therapeutics Sales

£885.00 08 Feb 2026
The 2023-2028 Outlook for Medical Foods in the United States
96% match

The 2023-2028 Outlook for Medical Foods in the United States

£520.00 24 Jan 2026
The 2025-2030 World Outlook for Digital Therapeutics Sales
96% match

The 2025-2030 World Outlook for Digital Therapeutics Sales

£790.00 09 Mar 2026
The 2025-2030 World Outlook for T-Cell Immunotherapies
96% match

The 2025-2030 World Outlook for T-Cell Immunotherapies

£790.00 31 Jan 2026
Multiple Sclerosis in Children and Adolescents - Medical Book
95% match

Multiple Sclerosis in Children and Adolescents - Medical Book

£139.75 19 Apr 2026
Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments
95% match

Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments

IntechOpen

£114.00 16 Feb 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
95% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India

£595.00 29 Jan 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
95% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China

£595.00 09 Mar 2026
The 2023-2028 World Outlook for Systemic Psoriasis Therapeutics
95% match

The 2023-2028 World Outlook for Systemic Psoriasis Therapeutics

£795.00 06 Feb 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in India
95% match

The 2023-2028 Outlook for Anti-Malarial Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Digital Therapeutics Sales in India
95% match

The 2023-2028 Outlook for Digital Therapeutics Sales in India

£515.00 26 Jan 2026
The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in Greater China
95% match

The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in Greater China

£595.00 24 Jan 2026